Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Therapeutic strategies for tauopathies and drug repurposing as a potential approach

Biochemical Pharmacology(2022)10.1016/j.bcp.2022.114979Source: DataRank Database

Therapeutic strategies for tauopathies and drug repurposing as a potential approach is a research paper published in Biochemical Pharmacology (2022). On theSindex it has a DataRank of 0. It has been cited 14 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access14 citations

Download PDF

Cite:

Linked data & code

nct doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (3 grants)Impact (FWCI 1.43)OA: greenTopics (43)IDs (PubMed, PMC, OpenAlex)Annotations (2)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (4)

Fengyun Shen,Deepika Regmi,Deguo Du ORCID,Majedul Islam ORCID

Live enrichment

PubMed:35219701 PMC:PMC9159505 OpenAlex:https://openalex.org/W4214511307

National Institutes of Health

Grant: R15GM116006

Alzheimer's Association

Grant: AARG-17-531423

National Institutes of Health

Grant: 2R15GM116006-02

Role of the N-terminal Region in Abeta Oligomer and Fibril Formation

FWCI

1.43

Citation Percentile

0.8%

Citation Trend

2022

2023

2024

2025

2026

greenLicense: Elsevier TDM

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/9159505

publisherhttps://api.elsevier.com/content/article/PII:S0006295222000739?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S0006295222000739?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.bcp.2022.114979

Fields of Study

Alzheimer's disease research and treatmentsNeurological Disorders and TreatmentsMedicinal Plants and Neuroprotection0301 basic medicine03 medical and health sciences0302 clinical medicineAlzheimer DiseaseBrainDrug RepositioningHumansTauopathiestau Proteins

MeSH Terms

Alzheimer DiseaseBrainHumanstau ProteinsTauopathiesDrug Repositioning

Keywords

Drug repositioningRepurposingMedicineDrugDiseaseDrug developmentClinical trialFood and drug administrationDrug discoveryIntensive care medicinePharmacologyBioinformaticsBiologyInternal medicineTauTauopathyMicrotubule (Mt)Post-translational Modifications (Ptms)Phosphorylated Tau (P-tau)Alzheimer's Disease (Ad), Neurofibrillary Tangles (Nfts)TauopathiesAlzheimer DiseaseBrainHumanstau Proteins

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being

Therapeutic strategies for tauopathies and drug repurposing as a potential approach

FAIR Checklist

Authors (4)

Funding (3 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)